ACMT position statement: the Iom report on thimerosal and autism.
Kurt
Tom L
TL
D001321:Autistic Disorder / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D017410:Practice Guidelines as Topic; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D012955:Societies, Medical; D013849:Thimerosal / Q000009:adverse effects*; D014481:United States; D014612:Vaccines / Q000009:adverse effects*
D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal